Reference
Numata T, et al. Sezary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody. Clinical and Experimental Dermatology 43: 281-285, No. 3, Apr 2018. Available from: URL: http://doi.org/10.1111/ced.13357 - Japan
Rights and permissions
About this article
Cite this article
Vorinostat. Reactions Weekly 1697, 386 (2018). https://doi.org/10.1007/s40278-018-44942-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-44942-8